503 reports of this reaction
3.6% of all PRASUGREL HYDROCHLORIDE reports
#1 most reported adverse reaction
MYOCARDIAL INFARCTION is the #1 most commonly reported adverse reaction for PRASUGREL HYDROCHLORIDE, manufactured by Cosette Pharmaceuticals, Inc.. There are 503 FDA adverse event reports linking PRASUGREL HYDROCHLORIDE to MYOCARDIAL INFARCTION. This represents approximately 3.6% of all 14,129 adverse event reports for this drug.
Patients taking PRASUGREL HYDROCHLORIDE who experience myocardial infarction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MYOCARDIAL INFARCTION is moderately reported among PRASUGREL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to myocardial infarction, the following adverse reactions have been reported for PRASUGREL HYDROCHLORIDE:
The following drugs have also been linked to myocardial infarction in FDA adverse event reports:
MYOCARDIAL INFARCTION has been reported as an adverse event in 503 FDA reports for PRASUGREL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MYOCARDIAL INFARCTION accounts for approximately 3.6% of all adverse event reports for PRASUGREL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience myocardial infarction while taking PRASUGREL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.